Neurocrine Biosciences reported $182.9M in Selling and Administration Expenses for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbvie ABBV:US USD 3.21B 4M
Acadia Pharmaceuticals ACAD:US USD 104.4M 26.29M
Acorda Therapeutics ACOR:US USD 26.25M 3.26M
Agios Pharmaceuticals AGIO:US USD 32.77M 3.65M
ALKERMES ALKS:US USD 157.54M 4.76M
Alnylam Pharmaceuticals ALNY:US USD 210.34M 25.52M
Amgen AMGN:US USD 1.47B 181M
Aptinyx Inc APTX:US USD 4.65M 547K
Biogen BIIB:US USD 632.8M 69.5M
Biomarin Pharmaceutical BMRN:US USD 245.74M 28.92M
Cytokinetics CYTK:US USD 53.97M 5.75M
Dynavax Technologies DVAX:US USD 30.38M 1.22M
Enanta Pharmaceuticals ENTA:US USD 12.7M 127K
Exelixis EXEL:US USD 119.25M 4.27M
Gilead Sciences GILD:US USD 2.02B 807M
Halozyme Therapeutics HALO:US USD 36.35M 2.28M
Intercept Pharmaceuticals ICPT:US USD 55.29M 12.02M
Intra Cellular Therapies ITCI:US USD 94.63M 6.26M
IONIS PHARMACEUT IONS:US USD 47.95M 13.53M
Nektar Therapeutics NKTR:US USD 21.94M 595K
Neurocrine Biosciences NBIX:US USD 182.9M 3.4M
Pfizer PFE:US USD 4.87B 1.33B
Prothena PRTA:US USD 13.12M 1.14M
Regeneron Pharmaceuticals REGN:US USD 660.5M 131.4M
Repligen RGEN:US USD 53.24M 406K
Rigel Pharmaceuticals RIGL:US USD 32.17M 6.28M
Sarepta Therapeutics SRPT:US USD 120.48M 15.69M
Teva Pharmaceutical TEVA:IT USD 837M 60M
Ultragenyx Pharmaceutical RARE:US USD 72.85M 3.01M
Vertex Pharmaceuticals VRTX:US USD 267.4M 20.6M
YTE INCY:US USD 272.82M 6.36M